Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes

Clinical and Experimental Immunology

Volumn 170, Issue 2, 2012, Pages 131-138

  Han, D ^a   Cai, X ^b   Wen, J ^b   Matheson, D ^a,c   Skyler, J S ^a,c   Kenyon, N S ^a,c   Chen, Z ^a,c  

^a UNIVERSITY OF MIAMI   (United States)

^b University of Miami College of Engineering   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; CTLA4; Diabetes; Gene expression; Human

Indexed keywords

ARGINASE; CD11B ANTIGEN; CD19 ANTIGEN; CD20 ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MESSENGER RNA; PROTEIN S 100; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ARGINASE GENE; ARTICLE; BLOOD SAMPLING; CD11B GENE; CD19 GENE; CD20 GENE; CD3G GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; IMMUNE GENE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ONSET AGE; PRIORITY JOURNAL; S100 GENE; TOLL LIKE RECEPTOR 9 GENE;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ANTIGENS, CD; ARGINASE; BIOLOGICAL MARKERS; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; RNA, MESSENGER; S100 PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84867221309     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04650.x     Document Type: Article

References (22)

1. Han D, Leyva CA, Matheson D etal. Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clin Immunol 2011; 139:290-301.
2. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H etal. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361:2143-52.
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
4. Leadbetter EA, Rifkin IR, Hohlbaum AM etal. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416:603-7.
5. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17:359-65.
6. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81:1-5.
7. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007; 3:382-90.
8. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74.
9. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004; 322:1111-22.
10. Mahon JL, Sosenko JM, Rafkin-Mervis L etal. The TrialNet natural history study of the development of type 1 diabetes: objectives, design, and initial results. Pediatr Diabetes 2009; 10:97-104.
11. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 2000; 1:170-84.
12. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24:65-97.
13. Shevach EM. Immunology. Regulating suppression. Science 2008; 322:202-3.
14. Wing K, Onishi Y, Prieto-Martin P etal. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322:271-5.
15. Zavattari P, Deidda E, Pitzalis M etal. No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes 2004; 53:1911-4.
16. Chen W, Jin W, Hardegen N etal. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86.
17. D'Alise AM, Ergun A, Hill JA etal. A cluster of coregulated genes determines TGF-{beta}-induced regulatory T-cell (Treg) dysfunction in NOD mice. Proc Natl Acad Sci USA 2011; 108:8737-42.
18. Turvey SE, Hawn TR. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol 2006; 120:1-9.
19. Ueda H, Howson JM, Esposito L etal. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-11.
20. Anjos SM, Shao W, Marchand L etal. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3′+6230G>A polymorphism. Genes Immun 2005; 6:305-11.
21. Chen Z, Stockton J, Mathis D etal. Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc Natl Acad Sci USA 2006; 103:16400-5.
22. Miska J, Bas E, Devarajan P etal. Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged self. Eur J Immunol 2012; doi: 10.1002/eji.201242590. [Epub ahead of print].